Skip to main content

Sources last read

What Mounjaro costs, and who each price is for

A month of Mounjaro costs $25 if your commercial plan covers it, and $499 if you have commercial insurance that does not. Lilly publishes no cash price for it at all.

Source: Read from Eli Lilly and Company’s own program terms, 2026-08-12

What matters first

Commercial insurance
Mounjaro Single-Dose Pen Savings Card: As little as $25 for a 1-month, 2-month or 3-month fill or As low as $499 for a 1-month fill
Without insurance
No manufacturer cash price is published
Medicare
Mounjaro is not in the Medicare GLP-1 Bridge. Medicare’s list of covered drugs names Foundayo, Wegovy and the Zepbound KwikPen, and rules out anyone whose reason for taking a GLP-1 is type 2 diabetes.

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewerReviewed 2026-08-12every price here is sourced

Every price here was read from the manufacturer’s own program terms on 2026-08-12. Those terms say they can change at any time, without notice. The terms themselves state that they expire on 2026-12-31 — after that date, treat every figure on this page as history until it has been read again.

What does Mounjaro cost if your plan covers it?

Mounjaro has the most generous card here and the narrowest gate. If your plan covers it, the card pays up to $150 a month and $1,950 a year. That is half as much again as the Zepbound card on both counts. If your plan does not cover it, the card absorbs up to $647 a month to hold you at $499. The gate is what the prescription says: Mounjaro is approved for type 2 diabetes, and a prescription written for weight loss does not clear that bar.

Mounjaro Single-Dose Pen Savings Card offers by insurance situation, read from the program terms on 2026-08-12
Your situationWhat Mounjaro costsWhat the card paysFills a year
Commercial insurance that covers MounjaroAs little as $25 for a 1-month, 2-month or 3-month fillThe card pays up to $150 a month, $300 for two months or $450 for three, and up to $1,950 in a calendar year13
Commercial insurance that does not cover MounjaroAs low as $499 for a 1-month fillThe card pays up to $647 a month and up to $8,411 in a calendar year13

Read from Eli Lilly and Companymanufacturer program terms · retrieved 2026-08-12 · the card’s own terms say it expires 2026-12-31

What does Mounjaro cost without insurance?

This is the one question on this page we cannot answer. The reason is worth stating plainly. Lilly publishes a full cash price list for Zepbound, dose by dose, on its own site. On the Mounjaro page the same company says only that the drug is sold for self-pay. No price, no dose table, no definition of a month.

Prices for it do circulate, from pharmacies and from discount cards. They move weekly and by zip code. Publishing one would mean passing somebody else’s changing number off as Lilly’s fixed one. So the absence stays on the page instead.

Eli Lilly and Company publishes no cash price for Mounjaro.

Lilly’s Mounjaro page says the drug is available through LillyDirect for self-pay and stops there. No price, no dose table, no month definition. We are not going to fill that gap with a number from a pharmacy or a discount site, because it would move next week and it would not be Lilly’s.

What if you are on Medicare?

Mounjaro is not in the Medicare GLP-1 Bridge. Medicare’s list of covered drugs names Foundayo, Wegovy and the Zepbound KwikPen, and rules out anyone whose reason for taking a GLP-1 is type 2 diabetes.

Mounjaro is outside the Bridge for the same reason as Ozempic. Medicare names Foundayo, Wegovy and the Zepbound KwikPen as the covered drugs, and separately rules out anyone taking a GLP-1 for type 2 diabetes. So there is no federal price for Mounjaro, and no manufacturer card either. What is left for a Medicare reader is ordinary Part D coverage, which is the route Medicare itself points at.

Who qualifies for the Medicare route, in full covers the weight thresholds, the conditions that go with them, and who is ruled out.

Read from Centers for Medicare & Medicaid Servicesfederal program page · retrieved 2026-08-12

4Price detailsPharmacy acquisition cost, eligibility rules, and price context

What does a pharmacy pay for Mounjaro?

This is the only page on this site where the federal file answers a question the manufacturer left blank. Lilly prints a full cash ladder for Zepbound and prints nothing for Mounjaro, so what a month costs without insurance has had no honest answer here at all.

It still does not have a price. What it has is a floor: what pharmacies report paying to buy it. Nobody is charged that, and what a pharmacy adds on top is not published anywhere.

Mounjaro is also the only tirzepatide product with no cheaper multi-dose option in this file. Zepbound has a KwikPen priced a third lower. Mounjaro’s KwikPen is not in the current file at all.

The single-dose pen

What a pharmacy reports paying for Mounjaro, single-dose pen, from the CMS weekly file of 12 August 2026
DoseCMS publishesA month works out atHow that was worked outIn force since
2.5 mg$538.61 per mL$1,077.22$538.61 per mL × 0.5 mL a pen × 4 pens = $1,077.222026-07-22
5 mg$538.58 per mL$1,077.15$538.58 per mL × 0.5 mL a pen × 4 pens = $1,077.152026-07-22
7.5 mg$538.63 per mL$1,077.26$538.63 per mL × 0.5 mL a pen × 4 pens = $1,077.262026-07-22
10 mg$538.60 per mL$1,077.21$538.60 per mL × 0.5 mL a pen × 4 pens = $1,077.212026-07-22
12.5 mg$538.45 per mL$1,076.90$538.45 per mL × 0.5 mL a pen × 4 pens = $1,076.902026-07-22
15 mg$538.46 per mL$1,076.92$538.46 per mL × 0.5 mL a pen × 4 pens = $1,076.922026-07-22

A month here means four single-dose pens, one a week, because the label doses Mounjaro once weekly. The per-unit figures are CMS’s; the monthly figures are ours, from that arithmetic.

Read down the single-dose pen table and the dose stops mattering. Every strength sits within 0.03 percent of every other, from $1,076.90 to $1,077.26 a month. What a pharmacy pays does not climb as the dose does.

What this number is not

  • It is an acquisition cost, not a patient price. What you pay is set by your plan, your pharmacy and any manufacturer program you qualify for, and none of those are in this file.
  • CMS prices these products per milliliter or per tablet. Any monthly figure on this site is our arithmetic on top of that, using the package size from the product’s own label, and it is labeled as derived wherever it appears.
  • Wholesalers, pharmacy benefit managers, plans and manufacturers settle further amounts between themselves that are not public. A difference between what a pharmacy pays and what anyone is charged is not evidence of wrongdoing, and this site does not present it as one.
  • Each row carries its own effective date, and CMS marks whether the figure came from the latest survey or was carried forward from an earlier file. Both are printed rather than averaged away.

Can you use the card at all?

Eli Lilly and Company sets conditions beyond the exclusion above, and you attest to all of them when you enroll. Getting one wrong is what turns a $25 month into a full-price one.

  • You are 18 or older and live in the United States or Puerto Rico.
  • You are enrolled in a commercial drug insurance plan.
  • You have a prescription for a use the Mounjaro label covers, which means type 2 diabetes rather than weight.

We do not print a code, and there is none to print. The card is issued by Eli Lilly and Company to you, after you say you meet those terms. Nothing on this page is an offer, and we do not supply, arrange or guarantee any discount.

What makes Mounjaro different on price

LillyDirect offers Mounjaro for self-pay but does not publish a price. Unlike Zepbound, there is no official self-pay figure to quote.

Mounjaro is tirzepatide from Eli Lilly and Company, approved under NDA 215866. Its price ladder tracks its dose ladder, which starts at 2.5 mg and stops at 15 mg. That is why a quote taken in your first month is a quote for a dose you are meant to leave.

Where to read next

Use the links below to continue with the pages available for this brand. Cost stays separate so each topic can be updated from its own source.

Questions readers ask

What is the cheapest way to get Mounjaro?

The savings card, if a commercial plan covers it: $25 a month, with the card absorbing up to $150 a month and $1,950 a year. That is the most generous card of the four.

Its gate is the narrowest, though. Mounjaro is approved for type 2 diabetes, and a prescription written for weight loss does not clear it.

How much does Mounjaro cost per month?

$25 with commercial insurance that covers it, and $499 with commercial insurance that does not.

For anyone without commercial insurance there is no published figure. Lilly says the drug is sold for self-pay and names no price.

What is the cheapest Mounjaro cost?

$25 a month, and only through the card with a covering commercial plan. Nothing published goes lower.

Medicare has no route to it at all. The GLP-1 Bridge names other products, and separately rules out anyone taking a GLP-1 for type 2 diabetes.

How much does Mounjaro CVS cost?

This is the one price question on this page that cannot be answered, and the reason is worth naming.

Lilly publishes a full cash price list for Zepbound, dose by dose, on its own site. On the Mounjaro page the same company says only that it is sold for self-pay. No price, no dose table, no definition of a month.

3 program documents — every price on this page was read from one of them
  1. Mounjaro Single-Dose Pen Savings Card eligibility, terms and conditions · Eli Lilly and Company · manufacturer program terms · retrieved 2026-08-12
  2. Weight loss drugs — what Medicare covers under the Medicare GLP-1 Bridge · Centers for Medicare & Medicaid Services · federal program page · retrieved 2026-08-12
  3. Medicare GLP-1 Bridge — frequently asked questions for plans and pharmacies · Centers for Medicare & Medicaid Services · federal program page · retrieved 2026-08-12

The pages beside this price

Mounjaro is a registered trademark of Eli Lilly and Company. This page is not written, reviewed or endorsed by Eli Lilly and Company, and nothing here is medical or financial advice. It reports what a public program document states, on the date it was read, so that you can check it before you budget.